Diabetes Tied to Identifiable Vocal Changes
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 1, 2023 -- Vocal changes appear to occur in individuals with type 2 diabetes mellitus (T2DM) versus those without diabetes, according to a study published online in the December issue of Mayo Clinic Proceedings: Digital Health.
Jaycee M. Kaufman, from Klick Inc. in Toronto, and colleagues investigated the potential of voice analysis as a prescreening or monitoring tool for T2DM. Voices were compared for 267 participants without diabetes (79 women and 113 men) and those with diabetes (18 women and 57 men).
The researchers observed significant differences between voice recordings of men and women with and without diabetes, both for the entire dataset and in an age-matched and body mass index (BMI)-matched sample. Overall, pitch and pitch standard deviation achieved the highest predictive accuracy. For women, relative average pertubation jitter was also significant, as were intensity and 11-point amplitude perturbation quotient shimmer for men. When combining these features with age and BMI, the optimal prediction models achieved accuracies of 0.75 for women and 0.70 for men in the age-matched and BMI-matched sample.
"Voice analysis shows potential as a prescreening or monitoring tool for T2DM, particularly when combined with other risk factors associated with the condition," the authors write.
Several authors are employees of Klick Inc., the source of funding for the study, and one author is listed as an inventor on two patents for the estimation of blood glucose using voice.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.